ArticleWorld journal of gastroenterology2009
Ceftriaxone-induced toxic hepatitis.
Article in World journal of gastroenterology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 37 citations in OpenAlex.
- Article
- Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury.European journal of clinical pharmacology · 2024Article
- Ceftriaxone-Associated Severe Acute Hepatitis.Cureus · 2023Article
- Histological Changes in Ovary Treated with Dexamethasone and Cefotaxime Sodium.Archives of Razi Institute · 2022Article
- A case of ceftriaxone-induced liver injury and literature review.Le infezioni in medicina · 2022Article
- Ceftriaxone-induced cholestatic hepatitis in a child: A case report and a review of the literature.Frontiers in pediatrics · 2022Article
- Cephalosporin's induced hepatic enzyme derangement - An educational report.Journal of family medicine and primary care · 2020Article
- Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases.Drug safety · 2017Article
- Drug-Induced Liver Injury: Pattern Recognition and Future Directions.Gut and liver · 2016Review
- Identification and Characterization of Cefazolin-Induced Liver Injury.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2015Article
- A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?Case reports in pediatrics · 2014Article
- Cholestatic hepatitis with intravenous ceftriaxone.Indian journal of pharmacology · 2011Article
- A rare case of cefepime-induced cholestatic liver injury.Tzu chi medical journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Toxic hepatitis or drug-induced liver injury encompasses a spectrum of clinical disease ranging from mild biochemical abnormalities to acute liver failure. The advantages of a long half-life, wide spectrum, high tissue penetration rate, and a good safety profile, make ceftriaxone, a third-generation cephalosporin, a frequent choice in the treatment of childhood infections. Previous studies have reported a few cases of high aspartate aminotransferase and alanine aminotransferase levels, along with three cases of hepatitis caused by ceftriaxone. Here, we report a case of drug-induced toxic hepatitis in a patient who was treated with ceftriaxone for acute tonsillitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.